1-10 of 10
Ying Tan
Close
Sort by
Journal Articles

Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Wei Ping Liu, Bo Jiang, Yue Rong Shuang, Xing Zhao, Xuan Fan Zhong, Ying Tan, Guo Jian Yu, Sheng Jie Xue, Wu Zhong Shen, Gui Yun Tu, Zheng Yang, Han Yang Chen, Jason Xu, Shui Liu, Xiao Qiang Qiang Yan, Jun Zhu, Yu Qin Song
Journal: Blood
Blood (2023) 142 (Supplement 1): 6158.
https://doi.org/10.1182/blood-2023-188071
Published: 2023
Journal Articles

High Deliverability of a Midostaurin Triplet Regimen Incorporating Venetoclax and Low Dose Cytarabine in Non-Adverse Cytogenetic Risk Acute Myeloid Leukaemia: A Sub-Analysis of the Australasian Leukaemia Lymphoma Group (ALLG) Intervene Study

Chong Chyn Chua, Natasha S Anstee, Anoop Kumar Enjeti, Devendra Hiwase, Paula Marlton, Ashish Bajel, Shuh Ying Tan, Edward S. Morris, Chun-Kei-Kris Ma, Carolyn Grove, Julian Cooney, Ashanka Beligaswatte, Rachel M Koldej, Stephen B Ting, Travis Perera, Amanda Johnston, John Reynolds, David Ritchie, Andrew H Wei
Journal: Blood
Blood (2022) 140 (Supplement 1): 3362–3364.
https://doi.org/10.1182/blood-2022-163084
Published: 2022
Journal Articles

Preliminary Safety and Efficacy of Bgb-11417, a Novel Bcl-2 Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML)

Jake Shortt, Pau Montesinos, Shuh Ying Tan, Teng Fong Ng, Chun Yew Fong, Paul Cannell, Rajeev Rajagopal, Sophia Leitch, Peter T. Tan, Sundra Ramanathan, Robin Gasiorowski, Douglas Stuart Lenton, Tse-Chieh Teh, José Antonio Pérez-Simón, Carolyn Grove, Xiaojun Huang, Courtney D. DiNardo, Katherine Naidu, Joseph Pariseau, Si Cheng, Yu Liu, Melannie Co, Wai Y. Chan, Haiyi Guo, Andrew H. Wei
Journal: Blood
Blood (2022) 140 (Supplement 1): 3329–3332.
https://doi.org/10.1182/blood-2022-166937
Published: 2022
Journal Articles

Effects of Ker-050 on Iron Metabolism: Exploratory Analyses from an Ongoing Phase 2 Study in Patients with Myelodysplastic Syndromes

Lynette C.Y. Chee, David M Ross, Shuh Ying Tan, Joel Wight, George Kannourakis, Miranda Ross, Wei Feng, Ying Jiang, Harveen Dhillon Natarajan, Christine Graham, Christopher Rovaldi, Simon Cooper, Jen L. Salstrom
Journal: Blood
Blood (2022) 140 (Supplement 1): 8181–8183.
https://doi.org/10.1182/blood-2022-166578
Published: 2022
Journal Articles

Modulation of TGF-β Superfamily Signaling to Treat Myelofibrosis and Mitigate JAK Inhibitor Toxicity: A Report on the Phase 2 Study of Ker-050 in Participants with Myelofibrosis

Claire Harrison, Shuh Ying Tan, David M Ross, George Kannourakis, Allie McGinty, Wei Feng, Ying Jiang, Christine Graham, Chris Rovaldi, Simon Cooper, Jen L. Salstrom
Journal: Blood
Blood (2022) 140 (Supplement 1): 9702–9703.
https://doi.org/10.1182/blood-2022-162761
Published: 2022
Journal Articles

An Australasian Leukemia Lymphoma Group (ALLG) Phase 2 Study to Investigate Novel Triplets to Extend Remission with Venetoclax in Elderly (INTERVENE) Acute Myeloid Leukemia

Chong Chyn Chua, John Reynolds, Anoop Kumar Enjeti, Devendra Hiwase, Paula Marlton, Ashish Bajel, Shuh Ying Tan, Edward S. Morris, Chun-Kei-Kris Ma, Carolyn Grove, Julian Cooney, Ashanka Beligaswatte, Natasha Anstee, Stephen B Ting, Travis Perera, Amanda Johnston, David Ritchie, Andrew H. Wei
Journal: Blood
Blood (2021) 138 (Supplement 1): 368.
https://doi.org/10.1182/blood-2021-149488
Published: 2021
Journal Articles

CD3-Activating Bi-Specific Antibody Targeting CD19 on B Cells in Mono- and Bi-Valent Format

Yumin CUI, PhD, Zhihua Huang, MSc, Xinfeng Zhang, PhD, Wuzhong Shen, MSc, Hanyang Chen, PhD, Zaiqing Wen, PhD, Bo Qi, MSc, Lan Luo, MSc, Ying Tan, Yun Wu, PhD, Ada Kung, PhD, Xiaoqiang Yan, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4169.
https://doi.org/10.1182/blood-2018-99-112819
Published: 2018
Journal Articles

Srsf2 P95H initiates myeloid bias and myelodysplastic/myeloproliferative syndrome from hemopoietic stem cells

Monique F. Smeets, Shuh Ying Tan, Jane Jialu Xu, Govardhan Anande, Ashwin Unnikrishnan, Alistair M. Chalk, Scott R. Taylor, John E. Pimanda, Meaghan Wall, Louise E. Purton, Carl R. Walkley
Journal: Blood
Blood (2018) 132 (6): 608–621.
https://doi.org/10.1182/blood-2018-04-845602
Published: 2018
Includes: Supplemental data
Journal Articles

Incorporating High-Dose IV Methotrexate Into Initial Therapy Results In Lower Rates Of Central Nervous System (CNS) Relapse In Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)

Chan Y Cheah, MBBS, FRACP, FRCPA, Kirsten Herbert, MD, BSci(Med), FRACP, PhD, Kacey O'Rourke, MBBS FRACP FRCPA, Glen Kennedy, MBBS FRACP FRCPA, Anupkumar George, MBBS FRACP FRCPA, Pasquale Fedele, MBBS, Shuh Ying Tan, MBBS, Stephen Opat, MBBS(Hons) FRACP FRCPA, Kate Burbury, MBBS, FRACP, FRCPA, DPhil, Max Wolf, MBBS, FRACP, FRCPA, Elchanan H. Januszewicz, MBBS FRACP FRCPA, Michael J. Dickinson, MBBS, FRACP, FRCPA, David A Westerman, MBBS, FRACP, FRCPA, H. Miles Prince, MBBS, FRACP, FRCPA, MD, Dennis A Carney, MBBS FRACP FRCPA, Simon J. Harrison, MBBS MRCP (uk) MRCPath (uk) PhD, Constantine S. Tam, MBBS, FRACP, FRCPA, MD, John F Seymour, MBBS, PhD, FRACP
Journal: Blood
Blood (2013) 122 (21): 4353.
https://doi.org/10.1182/blood.V122.21.4353.4353
Published: 2013
Journal Articles

PDE4 Inhibitors Block TLR7 and TLR9-Driven Signaling, Proliferation and Cytokine Secretion in CLL Cells As Well As Proliferation Driven by Exposure to Apoptotic Cells

Ying Tan, M.D., Ph.D., Amanda A. Watkins, Ian R. Rifkin, M.D., Ph.D., Adam Lerner, MD
Journal: Blood
Blood (2012) 120 (21): 1774.
https://doi.org/10.1182/blood.V120.21.1774.1774
Published: 2012